Filing Details

Accession Number:
0001209191-14-046570
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-09 17:37:40
Reporting Period:
2014-07-08
Filing Date:
2014-07-09
Accepted Time:
2014-07-09 17:37:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1245104 Globeimmune Inc GBIM Pharmaceutical Preparations (2834) 841353925
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1113661 J Daniel Mitchell C/O Sequel Limited Partnership Iii
4430 Arapahoe Avenue, Suite 220
Boulder CO 80303
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-07-08 6,961 $0.00 6,961 No 4 C Indirect By Sequel Entrepreneurs Fund III, LP
Common Stock Acquisiton 2014-07-08 250,645 $0.00 250,645 No 4 C Indirect By Sequel Limited Partnership III
Common Stock Acquisiton 2014-07-08 75,000 $10.00 325,645 No 4 P Indirect By Sequel Limited Partnership III
Common Stock Acquisiton 2014-07-08 10,000 $10.00 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Sequel Entrepreneurs Fund III, LP
No 4 C Indirect By Sequel Limited Partnership III
No 4 P Indirect By Sequel Limited Partnership III
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2014-07-08 36,557 $0.00 1,162 $0.00
Common Stock Series A Convertible Preferred Stock Disposition 2014-07-08 1,315,441 $0.00 41,904 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2014-07-08 84,879 $0.00 2,704 $0.00
Common Stock Series B Convertible Preferred Stock Disposition 2014-07-08 3,054,134 $0.00 97,296 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2014-07-08 75,318 $0.00 2,398 $0.00
Common Stock Series C Convertible Preferred Stock Disposition 2014-07-08 2,710,122 $0.00 86,335 $0.00
Common Stock Series E Convertible Preferred Stock Disposition 2014-07-08 21,905 $0.00 697 $0.00
Common Stock Series E Convertible Preferred Stock Disposition 2014-07-08 788,205 $0.00 25,110 $0.00
Common Stock Warrant to Purchase Series B Preferred Stock (right to buy) Disposition 2014-07-08 2,334 $1.34 2,334 $0.00
Common Stock Warrant to Purchase Series B Preferred Stock (right to buy) Disposition 2014-07-08 83,988 $1.34 83,988 $0.00
Common Stock Warrant to Purchase Series C Preferred Stock (right to buy) Disposition 2014-07-08 1,860 $1.45 1,860 $0.00
Common Stock Warrant to Purchase Series C Preferred Stock (right to buy) Disposition 2014-07-08 66,955 $1.45 66,955 $0.00
Common Stock Warrant to Purchase Common Stock (right to buy) Acquisiton 2014-07-08 74 $0.00 74 $42.00
Common Stock Warrant to Purchase Common Stock (right to buy) Acquisiton 2014-07-08 2,675 $0.00 2,675 $42.00
Common Stock Warrant to Purchase Common Stock (right to buy) Acquisiton 2014-07-08 59 $0.00 59 $45.36
Common Stock Warrant to Purchase Common Stock (right to buy) Acquisiton 2014-07-08 2,133 $0.00 2,133 $45.36
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
74 No 4 C Indirect
2,675 No 4 C Indirect
59 No 4 C Indirect
2,133 No 4 C Indirect
Footnotes
  1. Represents shares of common stock of the Issuer received upon conversion of shares of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock, and Series E Convertible Stock.
  2. Every one share of Series A Convertible Preferred Stock, Series B Convertible Preferred Stock, Series C Convertible Preferred Stock, and Series E Convertible Stock (collectively, the "Convertible Preferred Stock") converted on a 1-for- 31.39 basis into shares of common stock of the Issuer upon the closing of the Issuer's initial public offering. The Convertible Preferred Stock of the Issuer had no expiration and was convertible at any time at the option of the holder.
  3. Each one share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted on a 1-for-31.39 share basis into shares of common stock of the Issuer upon the closing of the Issuer's initial public offering. The number of shares and price per share reported herein does not reflect such conversion. The Warrant was immediately exercisable at any time at the option of the holder.
  4. Represents warrants to purchase shares of common stock of the Issuer following the conversion of the Series B Convertible Preferred Stock and Series C Convertible Preferred Stock on a 1-for-31.39 share basis. The number of shares and price per share reported herein reflects such conversion. The Warrant is immediately exercisable at any time at the option of the holder.
  5. The general partner of the Sequel Entrepreneurs Fund III, L.P. and Sequel Limited Partnership III (collectively, the "Sequel Funds") is Sequel Venture Partners III, L.L.C. ("SVP III"). SVP III may be deemed to indirectly beneficially own the shares owned by the Sequel Funds. The Reporting Person is a manager of SVP III and may be deemed to be the indirect beneficial owner of the shares owned by the Sequel Funds. The Reporting Person disclaims beneficial ownership of the shares held by the Sequel Funds, except to the extent of his pecuniary interest arising therein.